Bnb Plus CORP. (BNBX) — 8-K Filings

All 8-K filings from Bnb Plus CORP.. Browse 48 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (48)

8-K Filing — Dec 15, 2025
8-K Filing — Nov 17, 2025
Applied DNA Sciences Elects New Directors, Adjusts Executive Pay — Nov 10, 2025 Risk: medium
Applied DNA Sciences, Inc. announced on November 6, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two ne
Applied DNA Sciences Files 8-K — Nov 4, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on November 4, 2025, reporting an entry into a material definitive agreement and filing financial statements and exhibit
Applied DNA Sciences Files 8-K — Oct 23, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on October 23, 2025, reporting events as of October 21, 2025. The filing primarily concerns financial statements and exh
Applied DNA Sciences Files 8-K on Exit Costs — Oct 6, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on October 6, 2025, reporting on cost associated with exit or disposal activities as of September 30, 2025. The filing a
Applied DNA Sciences Files 8-K with Key Corporate Updates — Oct 1, 2025 Risk: medium
Applied DNA Sciences Inc. entered into a material definitive agreement on September 29, 2025. The company also reported on unregistered sales of equity securiti
Applied DNA Sciences Files 8-K with Material Agreements and Officer Changes — Sep 29, 2025 Risk: medium
On September 29, 2025, Applied DNA Sciences, Inc. filed an 8-K report detailing several key events. These include entering into a material definitive agreement,
Applied DNA Sciences Files 8-K on Financials — Aug 14, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition, and including financial statements a
Applied DNA Sciences Sells Certainty Business — Jul 7, 2025 Risk: medium
Applied DNA Sciences, Inc. announced on July 2, 2025, that it has entered into a definitive agreement to sell its Certainty business to an unaffiliated third pa
Applied DNA Sciences Files 8-K with Executive and Financial Updates — Jun 30, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on June 30, 2025, reporting events as of June 27, 2025. The filing indicates items related to cost associated with exit
Applied DNA Sciences Files 8-K with Officer/Director Updates — Jun 17, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on June 17, 2025, reporting events as of June 16, 2025. The filing indicates changes related to directors and officers,
Applied DNA Sciences Faces Delisting Concerns — Jun 6, 2025 Risk: high
Applied DNA Sciences, Inc. filed an 8-K on June 6, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the da
Applied DNA Sciences Files 8-K with Bylaw Amendments — May 29, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on May 29, 2025, reporting amendments to its Articles of Incorporation or Bylaws, a Regulation FD Disclosure, and Financ
Applied DNA Sciences Files 8-K on Shareholder Votes — May 22, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on May 22, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corp
Applied DNA Sciences Files 8-K on Financials — May 15, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition, and including financial statements and
Applied DNA Sciences Files 8-K — Apr 8, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on April 8, 2025, reporting other events and financial statements and exhibits. The filing date indicates the report was
Applied DNA Sciences Files 8-K on Shareholder Nominations — Apr 1, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on April 1, 2025, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing date for this repor
Applied DNA Sciences Files 8-K with Bylaw Amendments — Mar 12, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on March 12, 2025, reporting amendments to its articles of incorporation or bylaws, a Regulation FD disclosure, and fina
Applied DNA Sciences Files 8-K on Shareholder Votes — Feb 28, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on February 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain spec
Applied DNA Sciences Files 8-K on Shareholder Votes — Feb 14, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on February 14, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain spec
Applied DNA Sciences Files 8-K on Financials — Feb 13, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on February 13, 2025, reporting on its results of operations and financial condition. The filing includes financial stat
Applied DNA Sciences Changes Certifying Accountant — Jan 30, 2025 Risk: medium
Applied DNA Sciences, Inc. filed an 8-K on January 30, 2025, reporting a change in its certifying accountant. The company's previous independent registered publ
Applied DNA Sciences Files 8-K on Shareholder Votes — Jan 23, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on January 23, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's
Applied DNA Sciences Files 8-K — Jan 13, 2025 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on January 13, 2025, reporting information under Regulation FD and including financial statements and exhibits. The comp
Applied DNA Sciences Sells Certainty Business for $10M — Dec 17, 2024 Risk: medium
Applied DNA Sciences, Inc. announced on December 17, 2024, that it has entered into a definitive agreement to sell its Certainty business to an unaffiliated thi
Applied DNA Sciences Faces Delisting Concerns — Nov 13, 2024 Risk: high
Applied DNA Sciences, Inc. filed an 8-K on November 13, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The co
Applied DNA Sciences Files 8-K with Bylaw Amendments — Nov 7, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on November 7, 2024, reporting amendments to its Articles of Incorporation or Bylaws and submitting financial statements
Applied DNA Sciences Files 8-K: Material Agreement & Equity Sale — Oct 31, 2024 Risk: medium
Applied DNA Sciences, Inc. entered into a Material Definitive Agreement on October 30, 2024, related to the unregistered sale of equity securities. The company
Applied DNA Sciences Files 8-K on Security Holder Votes — Sep 30, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on September 30, 2024, to report on matters submitted to a vote of its security holders. The filing does not detail the
Applied DNA Sciences Sells Certainty Business for $15M — Sep 18, 2024 Risk: medium
Applied DNA Sciences, Inc. announced on September 17, 2024, that it has entered into a definitive agreement to sell its Certainty business to an unaffiliated th
Applied DNA Sciences Files 8-K on Financials — Aug 8, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial stateme
Applied DNA Sciences Files 8-K on Security Holder Votes — Aug 2, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on August 2, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's co
Applied DNA Sciences Faces Nasdaq Delisting Warning — Jul 15, 2024 Risk: high
Applied DNA Sciences, Inc. received a notification on July 12, 2024, from The Nasdaq Stock Market indicating that the company is not in compliance with the mini
Applied DNA Sciences Sells Certainty Business for $10M — Jun 28, 2024 Risk: medium
Applied DNA Sciences, Inc. announced on June 27, 2024, that it has entered into a definitive agreement to sell its Certainty business to an affiliate of the Gor
Applied DNA Sciences Files 8-K for Other Event — Jun 18, 2024 Risk: medium
On June 18, 2024, Applied DNA Sciences, Inc. filed an 8-K report detailing an "Other Event." The filing does not specify the exact nature of the event or any as
Applied DNA Sciences Enters Material Definitive Agreement — May 29, 2024 Risk: medium
Applied DNA Sciences, Inc. announced on May 28, 2024, that it entered into a Material Definitive Agreement. The company also disclosed information related to Re
Applied DNA Sciences Faces Nasdaq Delisting Warning — May 16, 2024 Risk: high
Applied DNA Sciences, Inc. filed an 8-K on May 16, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is facing p
Applied DNA Sciences Files 8-K on Financials — May 10, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on May 10, 2024, reporting on its results of operations and financial condition, as well as presenting financial stateme
8-K Filing — May 1, 2024
Applied DNA Sciences Files 8-K with Bylaw Amendments — Apr 22, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on April 22, 2024, reporting amendments to its Articles of Incorporation or Bylaws, a Regulation FD Disclosure, and fina
Applied DNA Sciences Enters Material Definitive Agreement — Apr 19, 2024 Risk: medium
Applied DNA Sciences, Inc. announced on April 16, 2024, that it entered into a Material Definitive Agreement. The company also reported on modifications to the
Applied DNA Sciences Files 8-K on Shareholder Votes — Apr 16, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on April 16, 2024, reporting on matters submitted to a vote of security holders as of April 15, 2024. The filing details
Applied DNA Sciences Files 8-K on Financial Condition — Feb 8, 2024 Risk: low
Applied DNA Sciences, Inc. filed an 8-K on February 8, 2024, to report on its results of operations and financial condition. This filing indicates that the comp
APDN: Material Agreement & Unregistered Equity Sale on Jan 31 — Feb 1, 2024
Applied DNA Sciences, Inc. (APDN) filed an 8-K on February 1, 2024, reporting an "Entry into a Material Definitive Agreement" and "Unregistered Sales of Equity
ADNAS Terminates Material Definitive Agreement, Effective Jan 30 — Jan 31, 2024
Applied DNA Sciences, Inc. (ADNAS) filed an 8-K on January 31, 2024, to report the termination of a material definitive agreement, effective January 30, 2024. T
APDN 8-K: Discloses Active Communications Under SEC Rules — Jan 8, 2024
Applied DNA Sciences, Inc. filed an 8-K on January 8, 2024, primarily to disclose that it is satisfying its filing obligations under various SEC rules, includin
Applied DNA Sciences Files 8-K for Corporate Event, M&A Implied — Jan 5, 2024
Applied DNA Sciences, Inc. filed an 8-K on January 5, 2024, reporting an event that occurred on January 4, 2024. This filing indicates that the company is using

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX